BDBM50438733 CHEMBL2414667

SMILES: Nc1ncnc2OCCN(c3ccc(cc3)[C@H]3CC[C@H](CC#N)CC3)C(=O)c12

InChI Key: InChIKey=SWUYRFGFZDOBPZ-SHTZXODSSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50438733   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Diacylglycerol O-acyltransferase 1 (DGAT1) (Homo sapiens (Human))	BDBM50438733 (CHEMBL2414667) Show SMILES Nc1ncnc2OCCN(c3ccc(cc3)[C@H]3CC[C@H](CC#N)CC3)C(=O)c12 |r,wU:16.16,wD:19.20,(28.43,-50.53,;28.37,-52.07,;27.01,-52.81,;26.96,-54.35,;28.27,-55.17,;29.63,-54.44,;30.8,-55.45,;32.31,-55.15,;33.03,-53.79,;32.4,-52.36,;33.42,-51.18,;34.91,-51.47,;35.91,-50.32,;35.41,-48.84,;33.93,-48.59,;32.93,-49.74,;36.43,-47.66,;35.94,-46.22,;36.94,-45.07,;38.43,-45.32,;39.44,-44.16,;40.96,-44.45,;42.47,-44.74,;38.94,-46.8,;37.93,-47.95,;30.93,-51.98,;30.63,-50.46,;29.68,-52.89,)| Show InChI InChI=1S/C21H23N5O2/c22-10-9-14-1-3-15(4-2-14)16-5-7-17(8-6-16)26-11-12-28-20-18(21(26)27)19(23)24-13-25-20/h5-8,13-15H,1-4,9,11-12H2,(H2,23,24,25)/t14-,15-	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	41	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addi...				Bioorg Med Chem 21: 5081-97 (2013) Article DOI: 10.1016/j.bmc.2013.06.045 BindingDB Entry DOI: 10.7270/Q26111RG
					More data for this Ligand-Target Pair
Diacylglycerol O-acyltransferase 1 (DGAT1) (Homo sapiens (Human))	BDBM50438733 (CHEMBL2414667) Show SMILES Nc1ncnc2OCCN(c3ccc(cc3)[C@H]3CC[C@H](CC#N)CC3)C(=O)c12 |r,wU:16.16,wD:19.20,(28.43,-50.53,;28.37,-52.07,;27.01,-52.81,;26.96,-54.35,;28.27,-55.17,;29.63,-54.44,;30.8,-55.45,;32.31,-55.15,;33.03,-53.79,;32.4,-52.36,;33.42,-51.18,;34.91,-51.47,;35.91,-50.32,;35.41,-48.84,;33.93,-48.59,;32.93,-49.74,;36.43,-47.66,;35.94,-46.22,;36.94,-45.07,;38.43,-45.32,;39.44,-44.16,;40.96,-44.45,;42.47,-44.74,;38.94,-46.8,;37.93,-47.95,;30.93,-51.98,;30.63,-50.46,;29.68,-52.89,)| Show InChI InChI=1S/C21H23N5O2/c22-10-9-14-1-3-15(4-2-14)16-5-7-17(8-6-16)26-11-12-28-20-18(21(26)27)19(23)24-13-25-20/h5-8,13-15H,1-4,9,11-12H2,(H2,23,24,25)/t14-,15-	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	64	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry				Bioorg Med Chem 21: 5081-97 (2013) Article DOI: 10.1016/j.bmc.2013.06.045 BindingDB Entry DOI: 10.7270/Q26111RG
					More data for this Ligand-Target Pair